Pay in 4 interest-free payments of $6.73 Learn more
Ships within 48 hours · Estimated delivery Nov 4 - Nov 9
Some of what you lose won't be fat, it'll be muscle
If you are in the first three months and feeling discouraged, the data says keep going
The doctor said I could not take another surgery so I have to live with it
Use a medical-grade cooler that maintains 28C consistently
Additionally, a Phase 2 open-label extension study evaluates long-term safety and efficacy of zasocitinib in 183 participants aged 1876 with both UC and CD who demonstrated clinical or symptomatic response at week 52 of their parent trials, focusing on treatment-emergent AEs and clinically significant changes in vital signs, laboratory values, and ECG over 108 weeks of continued treatment, having started in May 2025 with completion expected in December 2029 (NCT06764615)
